Tumor Necrosis Factor and Interleukin 1 Appearance in Experimental Gram-negative Septic Shock: The Effects of Plasma Exchange with Albumin and Plasma Infusion

Archives of Surgery

Volumn 126, Issue 5, 1991, Pages 591-597

  Busund, Rolf ^a   Lindsetmo, Rolv Ole ^a   Rasmussen, Lill Tove ^b   Røkke, Ola ^a   Rekvig, Ole P ^a   Revhaug, Arthur ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE SEPSIS; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL;

ANIMAL; BLOOD PRESSURE; BLOOD TRANSFUSION; BODY TEMPERATURE; CARDIAC OUTPUT; ENDOTOXINS; ESCHERICHIA COLI INFECTIONS; FEMALE; INTERLEUKIN-1; MALE; PLASMA EXCHANGE; SERUM ALBUMIN; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; SWINE; TUMOR NECROSIS FACTOR; VASCULAR RESISTANCE;

EID: 0025754010     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1991.01410290067014     Document Type: Article

References (32)

1. Hesse DG, Tracey KJ, Fong Y, et al. Cytokine appearance in human endotoxinemia and primate bacteremia. Surg Gynecol Obstet. 1988;166: 147-153.
2. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 1986;320:584-588.
3. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-474.
4. Tracey KJ, Lowry SF, Fahey TJ III, et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone response in the dog. Surg Gynecol Obstet. 1987;164:415-422.
5. Michie HR, Spriggs DR, Manogue KR, et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery. 1988;104:280-286.
6. Waage A, Halsetensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1:355-357.
7. Shalaby MR, Aggarwal BB, Rinderknecht E, Sverdersky LP, Finkle BS, Palladino MA. Activation of human polymorphonuclear neutrophil functions by interferon-g and tumor necrosis factor. J Immunol. 1985;135:2069-2073.
8. West MA. Macrophage effector function in sepsis. Arch Surg. 1987;122:242-247.
9. Movat H, Cybulsky MI. Neutrophil emigration and microvascular injury: role of chemotaxins, endotoxin, interleukin-1 and tumor necrosis factor alpha. Inflammation. 1987;6:153-176.
10. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med. 1986;163:1595-1601.
11. Nawroth PP, Stern D. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986;163:740-745.
12. Dinarello C, Cannon JG, Wolff SM. New concepts on the pathogenesis of fever. Rev Infect Dis. 1988;10:168-189.
13. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229:869-871.
14. Tracy K, Fong Y, Hesse D, et al. Anti-cachectin/TNF monoclonal antibody prevent septic shock during lethal bacteremia. Nature. 1987;330: 662-664.
15. Røkke O, Rasmussen L-T, Gierscsky KE, Seljelid R, Rekvig OP, Revhaug A. The influence of plasma exchange on shock mediators in septicemia. Surg Res Communications. 1990;8:173-182.
16. Røkke O, Lundgren TI, Revhaug A, Giercksky KE, Østerud B, Rekvig OP. Plasma exchange performed during severe gram negative septicemia: the influence on circulatory performance, plasma levels of endotoxin and bacterial counts in blood. Surg Res Communications. 1989;5:59-73.
17. Skau T. Intra-abdominal Infections Linköping, Sweden: Linköping University; 1984. Thesis.
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone, I: definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348-2357.
19. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986;95:99-105.
20. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods. 1983;65:55.
21. Gearing AJH, Bird CR, Bristow A, Poole S, Thorpe R. A simple sensitive bioassay for interleukin-1 which is unresponsive to 10 U/ml of interleukin-2. J Immunol Methods. 1987;99:7.
22. Stemberger A, Strasser F, von Hundelshausen B, Tempel G, Blumel G. Detection of plasma endotoxin with a limulus amoebocyte lysate (LAL)–chromogenic substrate assay. Acta Chir Scand. 1982;S509:49-53.
23. Mathison JC, Wolfson E, Ulveitch RJ. Participation of tumor necrosis factor in mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest. 1988;81:1925-1934.
24. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin Immunol Immunopathol. 1987;45:348-355.
25. Kampschmidt RF, Jones T. Rate of clearance of interleukin-1 from the blood of normal and nephrectomized rats. Proc Soc Exp Biol Med. 1985;180:170-173.
26. Kawakami M, Ikeda Y, Le Trang N, Vine W, Cerami A. Studies of conditions and agents that stimulate and inhibit the production of cachectin by macrophages. In: Patton W, ed. Proceedings of the IUPHAR. 2nd ed. New York, NY: Macmillan Publishing Co Inc; 1984:377-384.
27. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest. 1987;56:234-248.
28. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol. 1985;135:3972-3977.
29. Michie HR, Manogue KR, Spriggs DR, Revhaug A, Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988;318:1481-1486.
30. Havell EA. Production of tumor necrosis factor during murine listeriosis. J Immunol. 1987;139:4225-4231.
31. Drapkin S, Wisch JS, Gelfand JA, Cannon J, Dinarello C. Plasmapheresis for fulminant meningococcemia. Pediatr Infect Dis J. 1989;8:399-400.
32. Røkke O, Rekvig OP, Lundgren TI, Revhaug A. The treatment of severe gram negative septicemia with plasma exchange: effects mediated by extracorporal recirculation. Surg Res Communications. 1990;8:183-194.